Evidence map›Paper›PMID 25371656›Full record

ArticlePediatric rheumatology online journal2014

Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.

Ilaria Pagnini, Gabriele Simonini, Loredana Cavalli, Giancarlo la Marca, Annamaria Iuliano, Maria Luisa Brandi, Francesca Bellisai, Bruno Frediani, Mauro Galeazzi, Luca Cantarini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ilaria PagniniDepartment of Pediatrics, University of Florence, AOU Meyer, Rheumatology Unit, Viale Pieraccini 24, 50139 Florence, Italy.
Gabriele SimoniniDepartment of Pediatrics, University of Florence, AOU Meyer, Rheumatology Unit, Viale Pieraccini 24, 50139 Florence, Italy.
Loredana CavalliDepartment of Endocrinology, University of Florence, Florence, Italy.
Giancarlo la MarcaDepartment of Pediatrics, University of Florence, AOU Meyer, Rheumatology Unit, Viale Pieraccini 24, 50139 Florence, Italy.
Annamaria IulianoDepartment of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
Maria Luisa BrandiDepartment of Endocrinology, University of Florence, Florence, Italy.
Francesca BellisaiDepartment of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
Bruno FredianiDepartment of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
Mauro GaleazziDepartment of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
Luca CantariniDepartment of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
Rolando CimazDepartment of Pediatrics, University of Florence, AOU Meyer, Rheumatology Unit, Viale Pieraccini 24, 50139 Florence, Italy.
University of Siena · ITMeyer Children's Hospital · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate bone status in children born from mothers followed for autoimmune diseases and treated during pregnancy with low molecular weight heparin (LMVH) and/or prednisone.

findingsHistory, physical examination, laboratory tests and phalangeal ultrasonography were performed. Demographic, clinical, and laboratory data were entered into a customized database, and results were analyzed with SPSS software. In children whose mothers were treated with LMWH, we retrieved dried blood spots taken for newborn screening, and analyzed the presence of heparin with tandem mass spectrometry. We enrolled 27 females and 14 males born from 31 mothers with SLE or connective tissue diseases. These women were continuously treated during pregnancy with LMWH (n = 10), prednisone (n = 16), or both (n = 15). Bone ultrasound revealed low values (≤ 3 centile for age) in ten patients. In a multistep regression analysis, age at examination resulted the single predictor of low ultrasound values (p < 0.004). Tandem mass spectroscopy failed to determine traces of heparin in newborn blood.

conclusionsChildren born from mothers with autoimmune diseases are at risk to develop reduced bone mass. The administration of LMWH and of prednisone seems to be safe with regard to children's bone health.

Indexed as

Autoimmune DiseasesBone and BonesBone ResorptionChildChild, PreschoolConnective Tissue DiseasesDrug Therapy, CombinationFemaleFollow-Up StudiesHeparin, Low-Molecular-WeightHumansInfantLupus Erythematosus, SystemicMalePrednisonePregnancyHeparin, Low-Molecular-WeightPrednisoneAutoimmune diseasesCorticosteroidsHeparinOsteoporosisPregnancy

Identifiers

PMID25371656
PMCPMC4219046
OpenAlexW2129645221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.